Clinical trials recruiting for Histiocytic Sarcoma
Fewer than 3 recruiting trials found.
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Axl/Mer/CSF1R Inhibitor Q702 | 1 |
| Cobimetinib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Arizona | 2 |
| Arkansas | 1 |
| California | 1 |
| District of Columbia | 1 |
| Maryland | 1 |
| Massachusetts | 1 |
| Minnesota | 1 |
| New York | 1 |
| Tennessee | 1 |
| Texas | 1 |
| Wisconsin | 1 |
Top cities
Self-screener
Recruiting trials
- Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
- Q702 for the Treatment of Patients With Hematologic Malignancies
Related conditions
Trials recruiting for Histiocytic Sarcoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Histiocytic Sarcoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.